Global

Molecular Biology Experts

Toshiaki Abe

Professor
Department of Clinical Cell Therapy
Tohoku University
Japan

Biography

Dr. Yoko Aoki, is a Professor of Medical Genetics, at Tohoku University School of medicine. He is M.D. and Ph.D. His research themes are Drug delivery system for retinal diseases, Deployment type nanosheets creation technology development for biopharmaceutical local sustained release, Screening of the new vessel stimulant in the retina. Research Keywords for him are drug delivery, nano-sheet, retinal diseases, blindness prevention, neuroprotection.

Research Interest

Micro fabrication, controlled drug delivery, animal experiments, cell culture and gene manipulation, cell transplantation

Publications

  • Akasaki, Y., Kikuchi, T., Homma, S., Abe, T., Kofe, D., & Ohno, T. (2001). Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. Journal of Immunotherapy, 24(2), 106-113.

  • Ishibashi, T., Murayama, Y., Urashima, M., Saguchi, T., Ebara, M., Arakawa, H., ... & Abe, T. (2009). Unruptured intracranial aneurysms. Stroke, 40(1), 313-316.

  • Kikuchi, T., Akasaki, Y., Abe, T., Fukuda, T., Saotome, H., Ryan, J. L., ... & Ohno, T. (2004). Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12. Journal of Immunotherapy, 27(6), 452-459.

  • Kikuchi, T., Akasaki, Y., Irie, M., Homma, S., Abe, T., & Ohno, T. (2001). Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunology, Immunotherapy, 50(7), 337-344.

  • Joki, T., Heese, O., Nikas, D. C., Bello, L., Zhang, J., Kraeft, S. K., ... & Black, P. M. (2000). Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer research, 60(17), 4926-4931.

  • Joki, T., Machluf, M., Atala, A., Zhu, J., Seyfried, N. T., Dunn, I. F., ... & Black, P. M. (2001). Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature biotechnology, 19(1), 35.

Global Experts from Japan

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America